These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3022829)

  • 1. [Binding of reversible spin-labeled inhibitors with an butyrylcholinesterase active center].
    Dorokhov KE; Grigorian GL
    Biofizika; 1986; 31(5):746-51. PubMed ID: 3022829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interaction of spin-labeled methacyne analog with butyrylcholinesterase].
    Dorokhov KE; Grigorian GL; Kardanov NA; Zhdanov RI; Trifonova SA
    Biofizika; 1985; 30(1):23-6. PubMed ID: 2983779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in active site gorge dimensions of cholinesterases revealed by binding of inhibitors to human butyrylcholinesterase.
    Saxena A; Redman AM; Jiang X; Lockridge O; Doctor BP
    Biochemistry; 1997 Dec; 36(48):14642-51. PubMed ID: 9398183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Ni(2+), Co(2+), and Mn(2+) on desensitized butyrylcholinesterase prepared from human serum.
    Cengiz D; Cokugras AN; Tezcan EF
    Biol Trace Elem Res; 2003; 93(1-3):55-62. PubMed ID: 12835490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of Phe329 in binding of cationic triarylmethane dyes to human butyrylcholinesterase.
    Biberoglu K; Tacal Ö; Akbulut H
    Arch Biochem Biophys; 2011 Jul; 511(1-2):64-8. PubMed ID: 21530486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of two different cholinesterases by tacrine.
    Ahmed M; Rocha JB; Corrêa M; Mazzanti CM; Zanin RF; Morsch AL; Morsch VM; Schetinger MR
    Chem Biol Interact; 2006 Aug; 162(2):165-71. PubMed ID: 16860785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study of the binding of substrates and paramagnetic Mn2+ ions with phosphoglycerate kinase by saturating ESR spectra of a spin-labelled protein].
    Vlasova II; Kuprin SP
    Biofizika; 1992; 37(5):910-9. PubMed ID: 1335290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The peptidase site of butyrylcholinesterase is distinct from the esterase site].
    Chatonnet A; Masson P
    C R Acad Sci III; 1984; 299(13):529-34. PubMed ID: 6208983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intramolecular relationships in cholinesterases revealed by oocyte expression of site-directed and natural variants of human BCHE.
    Neville LF; Gnatt A; Loewenstein Y; Seidman S; Ehrlich G; Soreq H
    EMBO J; 1992 Apr; 11(4):1641-9. PubMed ID: 1373381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-site inhibition of human plasma cholinesterase by cationic phenoxazine and phenothiazine dyes.
    Küçükkilinç T; Ozer I
    Arch Biochem Biophys; 2007 May; 461(2):294-8. PubMed ID: 17428437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mechanistic model for butyrylcholinesterase.
    Eriksson H; Augustinsson KB
    Biochim Biophys Acta; 1979 Mar; 567(1):161-73. PubMed ID: 454620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probing the mid-gorge of cholinesterases with spacer-modified bivalent quinazolinimines leads to highly potent and selective butyrylcholinesterase inhibitors.
    Chen X; Tikhonova IG; Decker M
    Bioorg Med Chem; 2011 Feb; 19(3):1222-35. PubMed ID: 21232964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-silico identification of the binding mode of synthesized adamantyl derivatives inside cholinesterase enzymes.
    Al-Aboudi A; Al-Qawasmeh RA; Shahwan A; Mahmood U; Khalid A; Ul-Haq Z
    Acta Pharmacol Sin; 2015 Jul; 36(7):879-86. PubMed ID: 25937631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction study of two diterpenes, cryptotanshinone and dihydrotanshinone, to human acetylcholinesterase and butyrylcholinesterase by molecular docking and kinetic analysis.
    Wong KK; Ngo JC; Liu S; Lin HQ; Hu C; Shaw PC; Wan DC
    Chem Biol Interact; 2010 Sep; 187(1-3):335-9. PubMed ID: 20350537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential binding of phenothiazine urea derivatives to wild-type human cholinesterases and butyrylcholinesterase mutants.
    Darvesh S; Pottie IR; Darvesh KV; McDonald RS; Walsh R; Conrad S; Penwell A; Mataija D; Martin E
    Bioorg Med Chem; 2010 Mar; 18(6):2232-2244. PubMed ID: 20181484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition kinetics of human serum butyrylcholinesterase by Cd2+, Zn2+ and Al3+: comparison of the effects of metal ions on cholinesterases.
    Sarkarati B; Cokuğraş AN; Tezcan EF
    Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1999 Feb; 122(2):181-90. PubMed ID: 10190043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, molecular docking and biological evaluation of N,N-disubstituted 2-aminothiazolines as a new class of butyrylcholinesterase and carboxylesterase inhibitors.
    Makhaeva GF; Boltneva NP; Lushchekina SV; Serebryakova OG; Stupina TS; Terentiev AA; Serkov IV; Proshin AN; Bachurin SO; Richardson RJ
    Bioorg Med Chem; 2016 Mar; 24(5):1050-62. PubMed ID: 26827140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of Ni2+, Co2+, and Mn2+ on human serum butyrylcholinesterase.
    Cokuğraş AN; Cengiz D; Tezcan EF
    J Protein Chem; 2003 Aug; 22(6):585-9. PubMed ID: 14703992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of mono- and bis-N-substituted benzoquinolinium halides to butyrylcholinesterase: fluorescence measurements.
    Chen WS; Cocolas GH; Cavallito CJ
    J Pharm Sci; 1979 Aug; 68(8):1025-27. PubMed ID: 480157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of aging of mipafox-inhibited butyrylcholinesterase.
    Kropp TJ; Richardson RJ
    Chem Res Toxicol; 2007 Mar; 20(3):504-10. PubMed ID: 17323978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.